Healthcare
MBO Partenaires acquires Cellier, Orthofiga
MBO closed its fourth buyout fund, MBO Partenaires 4, on its €250m hard-cap last year
Deal in Focus: Ekkio Capital exits Amatsigroup
Under the GP's seven-year tenure, the pharmaceuticals business bolted on numerous competitors and acquired new laboratories
Accent Equity buys Oral Care
Accent Equity acquires Swedish dental provider Oral Care via its Accent Equity 2012 fund
KCP backs YorkTest MBO
YorkTest was a bolt-on for CBPE Capital's porftolio company Ingemino
1st Capital Partner leads series-A extension for Hemovent
Original funding round of $6m in February 2016 was provided by a consortium led by MIG Verwaltungs
GED acquires Vitro Group
Deal is the fifth acquisition for the GP's fifth vehicle, GED V España
Apposite Capital buys Swanton Care & Community
Deal is the GP's third acquisition across the European healthcare sector in 2017
Principia backs Trifarma MBO
Deal is the first majority acquisition for the GP's healthcare-dedicated vehicle, Principia III Health
Creathor and MTIP lead €14m round for Blueprint
Existing investors, including Inventure and Pontos Group, will also participate
Ufenau buys Karthaus
Horse breeder and billionaire Andreas Jacobs, the duke of Croy and CEO Victor Baltus will also hold shares
Ekkio Capital exits Amatsigroup
Amatsigroup is said to be valued at €130m in the transaction, non-inclusive of its residual debt
1717 Life Science Ventures announces €50m venture fund
1717 will now begin fundraising and expects to hold a final close within six to eight months
Bain, Cinven in increased bid for Stada
Following a failed bid in June, the GPs launch a new offer with a 25 cents increase
MB Rahastot sells Cityterveys to Synlab
Divestment comes from the GP's buyout vehicle, MB Equity Fund IV, which held a final close on тЌ260m
Gimv invests €15m in Arseus Medical
GP will draw capital for the transaction from its €150m Health & Care Fund, closed in March 2014
Bain, Cinven to bid again for Stada as CEO resigns
Stada CEO Matthias Wiedenfels has resigned today and will be replaced by Engelbert Coster Tjeenk Willink
Sun sells Nextpharma to Capvest
Sun says it strengthened senior management and optimised the manufacturing processes during its tenure
BioGeneration Ventures holds €66m close for Fund III
Having exceeded its original €50m target, the vehicle is aiming for a final close on €75m by year-end
Cobe buys Völker from Hill-Rom
End of a five-year holding period for Hill-Rom, which acquired Völker for $85m in February 2012
Bain and Cinven's Stada take-private bid fails
Offer narrowly misses the minimum acceptance condition, with 65.2% of Stada shares tendered
Idinvest in €12m round for M2i
Idinvest Growth Fund II was launched last year and held a first close on €250m in November
CM-CIC backs Le Normandy and Clinique Développement merger
CM-CIC started backing the Le Normandy group in 2000, structuring a €9.3m financing round
EQT buys 20% stake in Ottobock
GP will use capital from EQT VII to make the investment, based on a €3.15bn EV
BGF injects £3.85m into Dolphin Homes
Deal is the 12th transaction in 2017 for the UK-based growth capital investor
























